Reorganization at the US Food and Drug Administration (FDA) has led
to the former Division of Drug Marketing, Advertising and Communications
(DDMAC) being reorganized and upgraded to a new office, the Office of
Prescription Drug Promotion (OPDP). OPDP will include two divisions, one
overseeing promotions aimed at healthcare professionals and one for
direct-to-consumer promotions. Under the reorganization, the new office
will have more authority and resources than DDMAC. “This reorganization
will leverage OPDP’s resources and processes to provide for the highly
effective oversight of prescription drug promotion,” said Center for
Drug Evaluation and Research (CDER) Director Janet Woodcock in an email
to FDA staff.
Read more: